- 1 114
- 2 610 729
BioStock
Sweden
Приєднався 20 січ 2017
BioStock är Skandinaviens ledande digitala nyhets- och analystjänst med exklusivt fokus på bolag i Life Science-sektorn. Redaktionen är placerad på Medicon Village i Lund som är ett av Sveriges främsta innovationskluster för life science-bolag.
BioStocks innehåll riktar sig till investerare samt representanter för bolag och organisationer inom bioteknik, medicinteknik, diagnostik och läkemedelsutveckling. BioStocks dagliga nyhetsuppdateringar följs av en majoritet av beslutsfattare på ledningsnivå inom nordisk life science.
Genom att distribuera BioStocks nyheter, artiklar och intervjuer samt filmade investerarevent och kapitalmarknadsdagar parallellt i ett flertal kanaler samt via ett brett nätverk av mediapartners når BioStocks innehåll en bred bas av industriledare och investerare, såväl i Sverige som internationellt.
Allt innehåll som publiceras på BioStock kan och får delas förutsatt att hänvisning ges till källan, med undantag för tredje parts kommersiella syften.
BioStocks innehåll riktar sig till investerare samt representanter för bolag och organisationer inom bioteknik, medicinteknik, diagnostik och läkemedelsutveckling. BioStocks dagliga nyhetsuppdateringar följs av en majoritet av beslutsfattare på ledningsnivå inom nordisk life science.
Genom att distribuera BioStocks nyheter, artiklar och intervjuer samt filmade investerarevent och kapitalmarknadsdagar parallellt i ett flertal kanaler samt via ett brett nätverk av mediapartners når BioStocks innehåll en bred bas av industriledare och investerare, såväl i Sverige som internationellt.
Allt innehåll som publiceras på BioStock kan och får delas förutsatt att hänvisning ges till källan, med undantag för tredje parts kommersiella syften.
Scaling Up: Fueling Growth by Investing Strategically | Investing in Life Science 2024
Panel discussion themed “Scaling Up: Fueling Growth by Investing Strategically” that debated strategies of expert investment decisions within the life science space. What key factors are considered when predicting growth potential? What constitutes a validated investment case? What aspects are crucial for a company to attract investment?
Dawid Myslinski, a Partner at Vator Securities specializing in equity capital markets, moderated the panel. He was joined on stage by Karl Tobieson, CEO of Linc, a product-oriented life science investment firm; Karl-Fredrik Johannesson, founder of NV and a visionary investor; and Shamim Dadvar, a Medical Associate at HealthCap and MD turned life science venture capitalist.
On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who provide the funds.
From early-stage investments, where business angels and seed investors drive medical breakthroughs, to growth-stage investments empowering promising ventures to become ready for partnering and/or fueling market expansion and later-stage strategic investments accelerating growth and facilitating a global market presence.
The “Investing in life science: From seed to success” event catered to life science companies in all development stages, who gained insight from investors in the various life cycle stages, simultaneously providing investors a chance to pick the brains of peers, engage in thought-provoking discussions and meet life science companies in early-to-commercial stages.
Subscribe and follow BioStock on:
UA-cam bit.ly/Biostock
LinkedIn: www.linkedin.com/company/biostock
Facebook: biostock.se
www.biostock.se/
#BioStock #LifeScience
About BioStock
BioStock is Scandinavia's leading digital news and analysis service, exclusively focusing on the Life Science sector. Our primary editorial office and tv-studio are found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies
Dawid Myslinski, a Partner at Vator Securities specializing in equity capital markets, moderated the panel. He was joined on stage by Karl Tobieson, CEO of Linc, a product-oriented life science investment firm; Karl-Fredrik Johannesson, founder of NV and a visionary investor; and Shamim Dadvar, a Medical Associate at HealthCap and MD turned life science venture capitalist.
On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who provide the funds.
From early-stage investments, where business angels and seed investors drive medical breakthroughs, to growth-stage investments empowering promising ventures to become ready for partnering and/or fueling market expansion and later-stage strategic investments accelerating growth and facilitating a global market presence.
The “Investing in life science: From seed to success” event catered to life science companies in all development stages, who gained insight from investors in the various life cycle stages, simultaneously providing investors a chance to pick the brains of peers, engage in thought-provoking discussions and meet life science companies in early-to-commercial stages.
Subscribe and follow BioStock on:
UA-cam bit.ly/Biostock
LinkedIn: www.linkedin.com/company/biostock
Facebook: biostock.se
www.biostock.se/
#BioStock #LifeScience
About BioStock
BioStock is Scandinavia's leading digital news and analysis service, exclusively focusing on the Life Science sector. Our primary editorial office and tv-studio are found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies
Переглядів: 574
Відео
Promimic | Investing in Life Science 2024
Переглядів 539День тому
Magnus Larsson, CEO of Promimic, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who pr...
Initiator Pharma | Investing in Life Science 2024
Переглядів 638День тому
Claus Olesen, CEO of Initiator Pharma, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors ...
Spago Nanomedical | Investing in Life Science 2024
Переглядів 730День тому
Mats Hansen, CEO of Spago Nanomedical, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors ...
Prolight Diagnostics | Investing in Life Science 2024
Переглядів 789День тому
Ulf Bladin, CEO of Prolight Diagnostics, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investor...
Magle Chemoswed | Investing in Life Science 2024
Переглядів 619День тому
Justin Pierce, CEO of Magle Chemoswed, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors ...
CYTO356 | Investing in Life Science 2024
Переглядів 605День тому
Micael Törnblom, CEO of CYTO365, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who pr...
IRLAB Therapeutics | Investing in Life Science 2024
Переглядів 564День тому
Kristina Torfgård, CEO of IRLAB Therapeutics, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of inv...
PainDrainer | Investing in Life Science 2024
Переглядів 665День тому
Erik Frick, CEO of PainDrainer, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who pro...
Nurturing Innovation - Early-stage investments | Investing in Life Science 2024
Переглядів 595День тому
A panel discussion themed “Nurturing Innovation - Early-stage investments”. Moderator Thomas Gidlund, Head of Sales at Spotlight Stock Market - working exclusively with financing companies - dove deep on the topic with three distinct panelists; - Linda Spahiu Elvesjö, Investment Manager at Karolinska Development, with extensive experience of early-stage venture investments. - Christer Nordstedt...
Thor Medical | Investing in Life Science 2024
Переглядів 614День тому
Brede Ellingsaeter, CFO of Thor Medical, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investor...
ExpreS2ion Biotech | Investing in Life Science 2024
Переглядів 697День тому
Bent U. Frandsen, CEO of ExpreS2ion Biotech, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of inve...
Elicera Therapeutics | Investing in Life Science 2024
Переглядів 627День тому
Jamal El-Mosleh, CEO of Elicera Therapeutics, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of inv...
BioArctic | Investing in Life Science 2024
Переглядів 625День тому
Oskar Bosson, Head IR & Communication at BioArctic, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations ...
Ziccum | Investing in Life Science 2024
Переглядів 588День тому
Ann Gidner, CEO of Ziccum, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who provide ...
Unlocking Global Investment - How make Swedish Biotech Attractive | Investing in Life Science 2024
Переглядів 723День тому
Unlocking Global Investment - How make Swedish Biotech Attractive | Investing in Life Science 2024
Annexin Pharmaceuticals | Investing in Life Science 2024
Переглядів 656День тому
Annexin Pharmaceuticals | Investing in Life Science 2024
Zerion Pharma | Investing in Life Science 2024
Переглядів 635День тому
Zerion Pharma | Investing in Life Science 2024
Abarceo Pharma | Investing in Life Science 2024
Переглядів 675День тому
Abarceo Pharma | Investing in Life Science 2024
Eliceras målsökande virus mot cancer studeras i Kina
Переглядів 3 тис.14 днів тому
Eliceras målsökande virus mot cancer studeras i Kina
Cereno Scientific leaps towards phase II readout with CS1
Переглядів 6 тис.14 днів тому
Cereno Scientific leaps towards phase II readout with CS1
CLS prioriterar neurokirurgi över urologi
Переглядів 3 тис.14 днів тому
CLS prioriterar neurokirurgi över urologi
Annexin Pharmaceuticals: Can ANXV replace anti-VEGFs?
Переглядів 3 тис.14 днів тому
Annexin Pharmaceuticals: Can ANXV replace anti-VEGFs?
Abliva leads the way with potential mitochondrial disease treatment
Переглядів 2,9 тис.21 день тому
Abliva leads the way with potential mitochondrial disease treatment
How Magle Group focus their use of DSM
Переглядів 2,9 тис.21 день тому
How Magle Group focus their use of DSM
Deversify siktar på fler marknader och nästa utandningsmätare
Переглядів 2,9 тис.Місяць тому
Deversify siktar på fler marknader och nästa utandningsmätare
CB-certifikat lyfte Neola Medicals Q2
Переглядів 3 тис.Місяць тому
CB-certifikat lyfte Neola Medicals Q2
Deversify presenterar sitt erbjudande inom konsumenthälsa
Переглядів 2,9 тис.Місяць тому
Deversify presenterar sitt erbjudande inom konsumenthälsa
Cyxone uppdaterar utvecklingsplanen
Переглядів 3,1 тис.Місяць тому
Cyxone uppdaterar utvecklingsplanen
100% agree, I just realized that Mario updated his favorite way to tackle ED and it's crazy! Although what he previously talked about was pretty decent, it was difficult to follow, I just go'ogled the latest by Mario Volpstein, it's so much simpler and potent now!
100% agree, I just realized that Mario updated his favorite way to tackle ED and it's crazy! Although what he previously talked about was pretty decent, it was difficult to follow, I just go'ogled the latest by Mario Volpstein, it's so much simpler and potent now!
"Promosm"
Wooooooow beautiful ❤❤❤❤❤
Prenumerera och följ BioStock på: bit.ly/Biostock
Oncoinvent's CEO Anders Månsson presents the company in BioStock's Studio. Subscribe and follow BioStock at: bit.ly/Biostock
Evaxion Biotech's CEO Christian Kanstrup talks AI technology and cancer treatment with BioStock. Subscribe and follow BioStock at: bit.ly/Biostock
🎄!
En lysande pedagog!
BioStock intervjuar professor Tommy Andersson, medgrundare till WntResearch, som ger en uppdatering om bolaget. Prenumerera och följ BioStock på: bit.ly/Biostock
BioStock intervjuar Prostatype Genomics vd Fredrik Persson Följ och prenumerera på BioStock här: bit.ly/Biostock
Prostatype Genomics vd Fredrik Persson presenterar bolaget i BioStocks studio. Följ och prenumerera på BioStock här: bit.ly/Biostock
BioStock intervjuar Genetic Analysis vd Ronny Hermansen om bolagets GA-map-test och emissionen. Prenumerera och följ BioStock på: bit.ly/Biostock
BioStock intervjuar Jens Lindberg, vd för Medivir, om bolagets projekt och emission. Prenumerera och följ: bit.ly/Biostock
Prolight Diagnostics vd Ulf Bladin presenterar bolagets patientnära analyssystem, Psyros, samt företrädesemissionen som ska finansiera vägen fram till kommersialisering. Prenumerera och följ BioStock här: bit.ly/Biostock
BioStock intervjuar Prolight Diagnostics vd Ulf Bladin i samband med företrädesemissionen i december 2023. Prenumerera och följ BioStock här: bit.ly/Biostock
BioStock intervjuar Biovicas vd Anders Rylander om emissionen och bolagets cancertest. Prenumerera och följ BioStock här: bit.ly/Biostock
Biovicas vd Anders Rylander presenterar bolaget i BioStocks studio. Prenumerera och följ BioStock på: bit.ly/Biostock
Vd Ann Gidner presenterar Ziccum i BioStocks studio och berättar om de tre avtal man nu tecknat - ett för varje segment man riktar sig mot. Prenumerera och följ BioStock på: bit.ly/Biostock
👀
Subscribe and follow BioStock at: bit.ly/Biostock
Wow vilket bolag! Sveriges för tillfället mest intressanta biotech!
BioStock intervjuar Sten R. Sörensen, vd för Cereno Scientific, om bolaget justerade tidsplan i fas II-studien, ansökan om compassionate use samt det nyupptagna lånet. Följ och prenumerera på BioStock: bit.ly/Biostock
BioStock interviews Dan Mogren, CEO at CLS, about the company's Q3 and upcoming milestones. Subscribe and follow BioStock at: bit.ly/Biostock
BioStock interviews Torsten Freltoft, CEO of AcouSort, about the company's status and upcoming rights issue. Subscribe and follow BioStock at: bit.ly/Biostock
BioStock interviews Sarah Fredriksson, CEO of Aqilion, about the phase I-results with AQ280. Subscribe and follow BioStock at: bit.ly/Biostock
Cereno Scientific's Capital Markets Day 2023 (August 30) ua-cam.com/video/0wAb1CkqCqI/v-deo.html
BioStock interviews Cyxone's CEO Carl-Magnus Högerkorp and Maarten Kraan, Medical Advisor and member of the company's scientific advisory board. Subscribe and follow BioStock at: bit.ly/Biostock
BioStock intervjuar Elin Trampe, vd för Dicot om vad som hänt under Q3 och status i bolaget. Prenumerera och följ BioStock på: bit.ly/Biostock
Really really important step for Pancreatic cancer
Expert Insight: Optimizing chances of approval: How to achieve effective clinical and regulatory documents, overcome known obstacles and save time & money with Mathilde Thye Kveiborg, Director, Medical Writing, Aixial and Tanja Jensen, Senior Medical Writer, Aixial Subscribe and follow BioStock at: bit.ly/Biostock
Panel: "Business development, licensing & partnering - A Nordic outlook" with Any Balendran, Senior Licensing Director Global Business Development, Novo Nordisk and Tara Heitner, Head of Global Search and Alliance Management, Ferring Pharmaceuticals Subscribe and follow BioStock at: bit.ly/Biostock
Panel: "The evolving landscape of life science investment, funding & alternative sources of capital" with Johan Kördel, Managing Partner, Sound Bioventures and Pieter van der Meijden, Executive Director Life Sciences & Healthcare, Van Lanschot Kempen Subscribe and follow BioStock at: bit.ly/Biostock
Expert Insight: Stock Market Outlook with Carsten Borring, Head of Listings & Capital Markets, NASDAQ Copenhagen Subscribe and follow BioStock at: bit.ly/Biostock
TillaCare's CEO Michael Cohn pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
CombiGene's CEO Peter Ekolind presents the company at the BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Readily Diagnostics' CEO Liza Löf pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Cytely's CEO Philip Nordenfelt pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Peptonic Medical's CEO Erik Sundquist presents the company at the BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
IRLAB Therapeutic's CFO Viktor Siewertz presents the company at BioStock Life Science Summit in October 2023. Subscribe and follow BioStock at: bit.ly/Biostock
Authera's CEO Simone Mester pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Bionamic's CEO Anders Carlsson pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Lipigon's CEO Stefan K Nilsson presents the company at BioStock Life Science Summit in October 2023. Subscribe and follow BioStock at: bit.ly/Biostock
Nygen Analytics' CEO Parashar Dhapola pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Cyxone's CEO Carl-Magnus Högerkorp presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
MyCural Therapeutics' CEO Alina Castell pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
AcouSort's Commercial Director Agnes Michanek presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Paindrainer's CEO Erik Frick presents the company at BioStock Life Science Summit in October 2023 Subscribe and follow BioStock at: bit.ly/Biostock
SenzaGen's CEO Peter Nählstedt presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Aqilion's CEO Sarah Fredriksson presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock